Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer.
Rubovszky G, Kocsis J, Boér K, Chilingirova N, Dank M, Kahán Z, Kaidarova D, Kövér E, Krakovská BV, Máhr K, Mriňáková B, Pikó B, Božović-Spasojević I, Horváth Z. Rubovszky G, et al. Among authors: mahr k. Pathol Oncol Res. 2023 Jan 31;29:1610954. doi: 10.3389/pore.2023.1610954. eCollection 2023. Pathol Oncol Res. 2023. PMID: 36798671 Free PMC article.
[Systemic treatment of breast cancer: professional guideline].
Horváth Z, Boér K, Dank M, Kahán Z, Kocsis J, Kövér E, Máhr K, Pikó B, Rubovszky G. Horváth Z, et al. Among authors: mahr k. Magy Onkol. 2020 Dec 14;64(4):348-368. Epub 2020 Nov 30. Magy Onkol. 2020. PMID: 33313610 Free article. Hungarian.
[Linac-based stereotactic ablative radiotherapy for pancreatic cancer with intrafractional triggered imaging].
Kisiván K, Erdélyesi D, Gutyina D, Sajti P, Gugyerás D, Farkas A, Glavák C, László Z, Somogyiné Ezer É, Máhr K, Szabó Z, Szabó H, Cselik Z, Gulybán Á, Petőné Csima M, Káposztás Z, Lakosi F. Kisiván K, et al. Among authors: mahr k. Magy Onkol. 2021 Mar 17;65(1):6-13. Epub 2021 Jan 25. Magy Onkol. 2021. PMID: 33730111 Free article. Hungarian.
Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience.
Boér K, Kahán Z, Landherr L, Csőszi T, Máhr K, Ruzsa Á, Horváth Z, Budai B, Rubovszky G. Boér K, et al. Among authors: mahr k. Pathol Oncol Res. 2021 May 4;27:1609785. doi: 10.3389/pore.2021.1609785. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257621 Free PMC article.
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.
[Multicentric Hungarian results of cabozantinib therapy in patients with metastatic kidney cancer based on real-world data].
Maráz A, Nagyiványi K, Balogh I, Bodoky G, Mangel L, Küronya Z, Géczi L, Torday L, Dudás S, Szűcs M, Nagy Z, Hornyák L, Zolcsák Z, Bassam A, Kocsis J, Keresztes T, Kullmann T, Máhr K, Solymosi T, Papdán T, Szabó I, Varga Z, Biró K. Maráz A, et al. Among authors: mahr k. Magy Onkol. 2023 Mar 29;67(1):1-10. Epub 2023 Feb 4. Magy Onkol. 2023. PMID: 36989491 Free article. Hungarian.
[No title available]
[No authors listed] [No authors listed] PMID: 37086460
Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
Rubovszky G, Kocsis J, Boér K, Chilingirova N, Dank M, Kahán Z, Kaidarova D, Kövér E, Krakovská BV, Máhr K, Mriňáková B, Pikó B, Božović-Spasojević I, Horváth Z. Rubovszky G, et al. Among authors: mahr k. Pathol Oncol Res. 2022 Jul 11;28:1610383. doi: 10.3389/pore.2022.1610383. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35898593 Free PMC article.
61 results